ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Saturday, 21 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Adverse Business Impact

Medplus Health Services Adverse Business Impact

Medplus's subsidiary Optival Health Solutions had drug licences suspended for several stores by Telangana and Odisha regulators. Stated expected impact totals about Rs 0.09 Crore.

Key figures
Value₹0.09 Cr
Execution period1 to 3 days for four stores; until further notice for one store
Source

NSE filing, NSE: MEDPLUS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Medplus Health Services Ltd: key numbers

Share price
₹603.95
Market cap
₹7,257 Cr
Revenue (annual)
₹6,892 Cr
Net profit (annual)
₹219.7 Cr
P/E (TTM)
34.4×Sector 64.9×
Promoter holding
40.19%+0.00% QoQ
FII holding
12.58%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Medplus Health Services Ltd

All →

Other adverse business impact announcements

All →